Publications

Exploring Heterogeneity in Cost-Effectiveness Using Machine Learning Methods: A Case Study Using the FIRST-ABC Trial.

Hattab, Z; Doherty, E; SADIQUE, Z; Ramnarayan, P; O'NEILL, S;

2024

Medical care, (2024).62 7 10.1097/mlr.0000000000002010.

Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis.

Ryckman, TS; Schumacher, SG; Lienhardt, C; SWEENEY, S; Dowdy, DW; Mirzayev, F; Kendall, EA;

2024

The Lancet. Global health, (2024).12 6 10.1016/S2214-109X(24)00088-3.

Health care cost accounting in the Indian hospital sector.

Chugh, Y; Sharma, S; Mehndiratta, A; Sharma, D; Garg, B; Prinja, S; GUINNESS, L;

2024

Health policy and planning, (2024).39 7 10.1093/heapol/czae040.

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.

Roope, LS J; Morrell, L; Buchanan, J; Ledda, A; Adler, AI; JIT, M; Walker, AS; Pouwels, KB; Robotham, JV; Wordsworth, S; STEPUP team,;

2024

Communications medicine, (2024).4 1 10.1038/s43856-024-00516-9.

The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations.

Bonello, M; Applegate, TL; Badman, S; Bradshaw, CS; Broom, A; Field, P; Hocking, JS; Huston, WM; Kong, F; Murray, GL; Mokany, E; Pasricha, S; Todd, AV; Whiley, DM; WISEMAN, V; Guy, R;

2024

Microbiology Australia, (2024).45 2 10.1071/ma24017.

Persistence and heterogeneity of the effects of educating mothers to improve child immunisation uptake: Experimental evidence from Uttar Pradesh in India.

O'NEILL, S; GRIEVE, R; Singh, K; Dutt, V; POWELL-JACKSON, T;

2024

Journal of health economics, (2024).96, 10.1016/j.jhealeco.2024.102899.

An overview of the perspectives used in health economic evaluations.

Sittimart, M; Rattanavipapong, W; Mirelman, AJ; Hung, TM; Dabak, S; Downey, LE; JIT, M; Teerawattananon, Y; Turner, HC;

2024

Cost effectiveness and resource allocation, (2024).22 1 10.1186/s12962-024-00552-1.

Long-term healthcare utilisation, costs and quality of life after invasive group B Streptococcus disease: a cohort study in five low-income and middle-income countries.

Seedat, F; PROCTER, S; Dangor, Z; Leahy, S; Santhanam, S; John, HB; Bassat, Q; Aerts, C; Abubakar, A; Nasambu, C; Libster, R; Yanotti, CS; PAUL, P; Chanda, J; Gonçalves, BP; Horváth-Puhó, E; LAWN, JE; GBS Long-Term Outcomes LMIC Collaborative Group,; JIT, M;

2024

BMJ global health, (2024).9 5 10.1136/bmjgh-2023-014367.

Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.

Tumukunde, V; Medvedev, MM; TANN, CJ; Mambule, I; PITT, C; OPONDO, C; KAKANDE, A; Canter, R; Haroon, Y; Kirabo-Nagemi, C; ABAASA, A; Okot, W; Katongole, F; Ssenyonga, R; Niombi, N; NANYUNJA, C; ELBOURNE, D; GRECO, G; Ekirapa-Kiracho, E; NYIRENDA, M; ALLEN, E; Waiswa, P; LAWN, JE; OMWaNA Collaborative Authorship Group,;

2024

Lancet, (2024).403 10443 10.1016/S0140-6736(24)00064-3.

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.

BIDULKA, P; Lugo-Palacios, DG; CARROLL, O; O'NEILL, S; Adler, AI; Basu, A; Silverwood, RJ; BARTLETT, JW; NITSCH, D; Charlton, P; BRIGGS, AH; SMEETH, L; DOUGLAS, IJ; Khunti, K; GRIEVE, R;

2024

BMJ, (2024).385, 10.1136/bmj-2023-077097.